HRTX
Price
$1.29
Change
-$0.01 (-0.77%)
Updated
Oct 17 closing price
Capitalization
236.48M
18 days until earnings call
Intraday Buy/Sell Signals
LGVN
Price
$0.78
Change
-$0.05 (-6.02%)
Updated
Oct 17 closing price
Capitalization
16.39M
Intraday Buy/Sell Signals
Interact to see
Advertisement

HRTX vs LGVN

Header iconHRTX vs LGVN Comparison
Open Charts HRTX vs LGVNBanner chart's image
Heron Therapeutics
Price$1.29
Change-$0.01 (-0.77%)
Volume$640.73K
Capitalization236.48M
Longeveron
Price$0.78
Change-$0.05 (-6.02%)
Volume$622.17K
Capitalization16.39M
HRTX vs LGVN Comparison Chart in %
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
HRTX vs. LGVN commentary
Oct 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRTX is a Hold and LGVN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 18, 2025
Stock price -- (HRTX: $1.29 vs. LGVN: $0.78)
Brand notoriety: HRTX and LGVN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HRTX: 41% vs. LGVN: 67%
Market capitalization -- HRTX: $236.48M vs. LGVN: $16.39M
HRTX [@Biotechnology] is valued at $236.48M. LGVN’s [@Biotechnology] market capitalization is $16.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.87B to $0. The average market capitalization across the [@Biotechnology] industry is $2.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HRTX’s FA Score shows that 0 FA rating(s) are green whileLGVN’s FA Score has 0 green FA rating(s).

  • HRTX’s FA Score: 0 green, 5 red.
  • LGVN’s FA Score: 0 green, 5 red.
According to our system of comparison, LGVN is a better buy in the long-term than HRTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HRTX’s TA Score shows that 3 TA indicator(s) are bullish while LGVN’s TA Score has 3 bullish TA indicator(s).

  • HRTX’s TA Score: 3 bullish, 6 bearish.
  • LGVN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, LGVN is a better buy in the short-term than HRTX.

Price Growth

HRTX (@Biotechnology) experienced а +0.78% price change this week, while LGVN (@Biotechnology) price change was -4.23% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.56%. For the same industry, the average monthly price growth was +15.88%, and the average quarterly price growth was +79.09%.

Reported Earning Dates

HRTX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+1.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
HRTX($236M) has a higher market cap than LGVN($16.4M). HRTX YTD gains are higher at: -15.686 vs. LGVN (-55.017). HRTX has higher annual earnings (EBITDA): 7.54M vs. LGVN (-18.35M). HRTX has more cash in the bank: 40.6M vs. LGVN (10.3M). LGVN has less debt than HRTX: LGVN (1.14M) vs HRTX (177M). HRTX has higher revenues than LGVN: HRTX (150M) vs LGVN (2.07M).
HRTXLGVNHRTX / LGVN
Capitalization236M16.4M1,439%
EBITDA7.54M-18.35M-41%
Gain YTD-15.686-55.01729%
P/E RatioN/A3.11-
Revenue150M2.07M7,236%
Total Cash40.6M10.3M394%
Total Debt177M1.14M15,526%
FUNDAMENTALS RATINGS
HRTX: Fundamental Ratings
HRTX
OUTLOOK RATING
1..100
6
VALUATION
overvalued / fair valued / undervalued
1..100
52
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
HRTXLGVN
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
76%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
83%
Advances
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 11 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
HRTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LGVN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FCOB18.100.10
+0.56%
1st Colonial Bancorp, Inc.
GLNS1.11N/A
N/A
Golden Star Resource Corp
SVKEF18.67N/A
N/A
Skandinaviska Enskilda Banken AB
DFYFF50.28N/A
N/A
DEFINITY FINL CORP.
WTSHF17.75-0.23
-1.29%
Westshore Terminals Investment Corp.

HRTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, HRTX has been loosely correlated with GSGTF. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if HRTX jumps, then GSGTF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HRTX
1D Price
Change %
HRTX100%
-0.77%
GSGTF - HRTX
45%
Loosely correlated
N/A
AMRN - HRTX
44%
Loosely correlated
-2.14%
CYCN - HRTX
42%
Loosely correlated
-0.44%
AXON - HRTX
38%
Loosely correlated
+2.84%
ARRY - HRTX
36%
Loosely correlated
-0.17%
More

LGVN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LGVN has been loosely correlated with RXRX. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if LGVN jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LGVN
1D Price
Change %
LGVN100%
-5.96%
RXRX - LGVN
38%
Loosely correlated
-7.86%
QURE - LGVN
37%
Loosely correlated
-3.32%
BIVI - LGVN
36%
Loosely correlated
+3.24%
HRTX - LGVN
36%
Loosely correlated
-0.77%
SNGX - LGVN
36%
Loosely correlated
+6.45%
More